Double Marker Test in Pregnancy: What It Detects and Why Timing Matters

A pregnancy entails numerous tests, and the Double Marker Test is essential in the first trimester of pregnancy.

What Is a Double Marker Test?

Double marker test during pregnancy is a maternal blood test. It is used to determine the risk of chromosomal abnormalities in the developing foetus. Usually, it is done as a part of first trimester combination screening with an ultrasound scan.
Despite its name, the test does not look for a disease directly. It measures two substances in the mother’s blood:

• Free beta-human chorionic gonadotropin (free β-hCG)
• Pregnancy-associated plasma protein A (PAPP-A)

The measured levels are interpreted according to gestational age and combined with factors such as maternal age and ultrasound findings to calculate an estimated risk.

Abnormal patterns of these markers can be associated with chromosomal conditions. First-trimester screening may also contribute to assessment of other aneuploidies, depending on the screening approach used.

Importantly, the double marker test is simply a screening test. A high-risk result indicates a higher likelihood of the foetus having a chromosomal issue, but it doesn’t guarantee that it definitely does.

Why Is the Double Marker Test Important in Early Pregnancy?

The first trimester offers an early window of opportunity to evaluate the risk for common chromosomal abnormalities. This information may be obtained quite early by the double marker test in pregnancy and provides healthcare providers and parents with more time to consider additional screening or diagnostic tests if required.

The blood findings are more helpful if they are analysed in conjunction with the NT ultrasound and maternal variables. First-trimester screening usually includes an ultrasound to assess the nuchal translucency (NT) and a blood test of the mother’s blood, done early in the first trimester, ACOG says.

It’s especially helpful to have a risk assessment early on if there’s a history of chromosomal abnormalities, an odd result on ultrasound, or other concerns that merit closer investigation. However, prenatal screening options are not limited to women who are at high risk; they can be explored and offered in pregnancy regardless of maternal age or baseline risk.

When Should You Take the Double Marker Test?

The test is often performed between 11 and 14 weeks of gestation. However, first trimester combination screening is typically performed earlier in the first trimester.

Why does timing matter? The concentrations of pregnancy-related biochemical markers change as pregnancy progresses. The NT measurement also has a specific gestational-age window in which it is useful for first-trimester screening. Therefore, the results need to be interpreted in relation to the correct gestational age.

How Is the Double Marker Test Performed?

The double marker test is just a blood test taken during pregnancy.
A healthcare professional collects a sample of maternal blood. Then, the sample is investigated for free β-hCG and PAPP-A. The results are analysed together with information such as gestational age, maternal age and NT ultrasound findings.

How to Understand Your Double Marker Test Report

A double marker test in pregnancy report provides an estimated probability or risk category.

The report may include:

• Free β-hCG level
• PAPP-A level
• Gestational age
• Maternal age
• NT measurement or other ultrasound information
• A calculated risk estimate, often expressed as a ratio

Results may be described as low risk, intermediate/moderate risk, or high risk, depending on the laboratory’s reporting system.

A low risk result means the estimated likelihood of the examined chromosomal disorders is reduced. This does not imply that the probability is zero.

A high-risk result means there is a greater chance and generally a discussion with the obstetrician or genetics specialist about what to do next. It should not be used for diagnosis.

What Can Affect Double Marker Test Results?

Several factors as follows:

• Maternal age
• Accurate gestational age
• Maternal weight
• Singleton or multiple pregnancy
• Pregnancy achieved through assisted reproductive techniques
• Diabetes and certain maternal factors
• Fetal or placental factors
• NT ultrasound measurement
• Laboratory-specific reference ranges

Maternal age is particularly relevant because the background risk of chromosomal abnormalities changes with age.

What Happens After a High-Risk Double Marker Test?

A high-risk double marker test result in pregnancy does not necessarily signify that the foetus has a chromosomal issue. Depending on the specific clinical circumstances, further screening or diagnostic tests might be the next step.

CVS may often be performed earlier in pregnancy, although amniocentesis is usually performed later, normally at 15 weeks and beyond. Screening tests can give considerably more definitive information than diagnostic procedures which investigate foetal or placental cells.

What Are the Benefits and Limitations of the Double Marker Test?

The double marker test in pregnancy has an important role in early risk assessment, but it should always be understood as one part of prenatal care.

Key Benefits of First-Trimester Screening

First-trimester screening can:

• Provide an early estimate of the risk of common chromosomal abnormalities.
• Combine biochemical markers with ultrasound findings.
• Help identify pregnancies that may benefit from further evaluation.
• Give parents more time to understand their options.
• Avoid invasive testing for many pregnancies that screen as low risk.

Why the Double Marker Test Cannot Confirm a Diagnosis

The biggest limitation is interpretation. A screening test estimates risk; it does not establish whether a condition is actually present.
A high-risk result can occur even when the fetus does not have the suspected condition, known as a false-positive result. Conversely, a low-risk result cannot completely exclude an abnormality because false-negative results can occur.

Frequently Asked Questions

Is the double marker test mandatory during pregnancy?

No. The double marker test in pregnancy is not mandatory. It is a decision to undergo a prenatal screening. You can discuss it with your obstetrician.

Can the double marker test be done without an ultrasound?

The blood test can be collected individually however the interpretation of the blood test is frequently meant to be paired with ultrasound data, especially the NT value, for first-trimester combination screening. Your doctor or the laboratory can tell you which test method is being utilised.

What happens if the double marker test is missed in the first trimester?

If you miss your double marker test, there are alternative prenatal screening methods that can still be accessible such as cell-free DNA screening which can normally be conducted from 10 weeks.

Is the double marker test safe for the baby?

The double marker test in pregnancy is a non intrusive procedure and requires taking a blood sample from the mother.

How is a double marker test different from NIPT?

Both are screening tests but they use different information The double marker test assesses maternal blood indicators, including as free β-hCG and PAPP-A, and is often interpreted in conjunction with first-trimester ultrasound data. NIPT, or cell-free DNA screening, examines tiny quantities of placental DNA in the mother’s blood. NIPT may be conducted from about 10 weeks and is a very sensitive screening tool for common foetal aneuploidies, but is not yet diagnostic.

Can a low-risk double marker result guarantee a healthy baby?

No. A low risk double marker test in pregnancy will reduce the chance of the chromosomal problems that are looked for but cannot guarantee the baby is free of any genetic diseases, congenital deformity or pregnancy complication.